Johnson & Johnson

JNJ

Johnson & Johnson is an American multinational corporation founded in 1886 that develops medical devices, pharmaceutical, and consumer packaged goods. Its common stock is a component of the Dow Jones Industrial Average and the company is ranked No. 37 on the 2018 Fortune 500 list of the largest Unit …

Insider trades and stock quote 2024-2026

All insider trades at Johnson & Johnson

Subscribe RSS
Date Type Insider Position Ø-Price Volume
8/6/2026 Sell Forminard, Elizabeth EVP, Chief Legal Officer $256.8 $4,090,960
8/5/2026 Sell Duato, Joaquin CEO and Chairman of the Board $258.4 $12,515,010
7/20/2026 Sell Broadhurst, Vanessa EVP, Global Corp Affairs $251.3 $5,792,686
6/11/2026 Sell Wengel, Kathryn E. EVP, Chief TO and Risk Officer $241.2 $2,411,500
2/27/2026 Sell Decker, Robert J. VP Corporate Controller $247.9 $1,010,070
2/20/2026 Sell Schmid, Timothy EVP, WW Chair, MedTech $245.7 $324,763
2/18/2026 Sell Schmid, Timothy EVP, WW Chair, MedTech $244.4 $5,527,506
2/17/2026 Sell Broadhurst, Vanessa EVP, Global Corp Affairs $243.4 $1,508,288
2/17/2026 Sell Reed, John C. EVP, Innovative Medicine, R&D $243.0 $13,105,233
2/17/2026 Sell Wolk, Joseph J. Exec VP, CFO $242.8 $21,767,827
2/17/2026 Sell Swanson, James D. EVP, CIO $242.7 $4,980,447
2/13/2026 Sell Swanson, James D. EVP, CIO $243.7 $10,129,313
1/26/2026 Sell Duato, Joaquin CEO and Chairman of the Board $221.2 $22,122,893
11/26/2025 Buy Morikis, John G. Director $206.2 $257,688
10/17/2025 Sell Reed, John C. EVP, Innovative Medicine, R&D $192.7 $4,185,793
9/4/2025 Sell Taubert, Jennifer L. EVP, WWC. Innovative Medicine $177.8 $10,040,883
8/22/2025 Sell Duato, Joaquin CEO and Chairman of the Board $179.2 $22,548,655
8/15/2025 Sell Wolk, Joseph J. Exec VP, CFO $176.9 $2,975,571
7/17/2025 Sell Reed, John C. EVP, Innovative Medicine, R&D $163.5 $3,129,830
2/25/2025 Sell Decker, Robert J. VP Corporate Controller $165.9 $1,160,994
2/18/2025 Sell Schmid, Timothy EVP, WW Chair, MedTech $156.2 $62,928
2/7/2025 Sell Wolk, Joseph J. Exec VP, CFO $153.9 $2,002,878
12/12/2024 Buy Weinberger, Mark A. Director $147.2 $147,220
8/30/2024 Sell Decker, Robert J. VP Corporate Controller $165.1 $930,113
All information without guarantee! No recommendation/consultation! © U.S. Securities and Exchange Commission (SEC)